Primary objective | |
• To compare measurements of FMD of the brachial artery in hypertensive individuals receiving either an α1-adrenergic blocker or placebo after sessions of different types of exercise. | |
Secondary objectives | |
• To compare the effects of ANS activation in hypertensive individuals receiving either an α1-adrenergic blocker or placebo (between-group) in response to acute exercise (aerobic, resistance and combined exercise sessions); | |
• To correlate the levels of arterial stiffness and ANS activation and FMD of the brachial artery in hypertensive individuals receiving either an α1-adrenergic blocker or placebo in response to acute exercise (aerobic, resistance, and combined exercise sessions). |